Analysis for MO

📈 Growth & Financial Trajectory

Eight quarters show revenue around $6.26B to $6.11B with a slight overall dip, while net income grows from about $1.96B to $2.30B despite volatility (notably a spike in 2024 Q4 and a dip in 2025 Q1). The trend remains resilient with earnings advancing as the period ends.

💰 Margins & Cash Flow

Gross margins run around 63–65%, with gross profit roughly $3.25B–$3.81B on revenue of about $5.97B–$6.26B. Operating margins hover in the high 40s to low 50s overall, with some quarters near mid-50s. Net cash from operating activities is typically positive, including peaks near $3.3B; investing cash flow is modestly negative and financing activity varies.

🛡️ Balance Sheet & Liquidity

Total assets around $33–$38B; liabilities in the mid-to-high tens of billions; equity at the parent level is frequently negative (e.g., -$2.2B to -$3.3B). Long-term debt in the mid- to high-$20B range. Near-term liquidity shows current assets around $5.1B vs. current liabilities near $8.3B, indicating tighter short-term liquidity despite strong cash generation.

⚠️ Key Drivers & Risks

• Drivers: steady pricing power in core tobacco products; robust operating cash flow supports debt management.
• Risks: regulatory/litigation exposure and leverage/negative equity pressures; revenue growth remains modest and sensitive to macro shifts.